Reid Hoffman and Siddhartha Mukherjee Launch AI Startup Manas AI with $24.6M Funding

Manas AI aims to revolutionize cancer drug discovery using AI, starting with treatments for breast cancer, prostate cancer, and lymphoma.

Manas AI, co-founded by LinkedIn's Reid Hoffman and oncologist Siddhartha Mukherjee, raised $24.6 million in seed funding led by General Catalyst and Greylock Partners.
The startup will use proprietary AI technology to accelerate drug discovery, focusing initially on breast cancer, prostate cancer, and lymphoma before expanding to autoimmune diseases and rare conditions.
Manas AI plans to integrate AI-driven molecular design with wet lab testing to identify and develop promising drug candidates more efficiently.
The company has partnered with Microsoft to leverage its Azure cloud computing platform and AI expertise to support its drug discovery efforts.
Hoffman and Mukherjee emphasize that the technology is meant to empower researchers, combining advanced AI with the expertise of leading scientists to transform drug development timelines and costs.